Indeed, the treatment increased H19 mRNA expression, inhibited IGF-2 mRNA and decreased cellular proliferation.[106] These results provide a rationale to further investigate the efficacy of DNA demethylating agents in ACC. Here, H19 is linked to adrenal cortex carcinoma.